Ceftazidime: aspects of efficacy and tolerance

Related Experiment Video

Updated: Aug 19, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

R D Foord

    The Journal of Antimicrobial Chemotherapy
    |July 1, 1983
    PubMed

    Insights

    Ceftazidime demonstrated comparable efficacy to other antibiotics for staphylococcal infections but showed higher clearance rates for pseudomonas infections. Adverse events and superinfections were similar, with lower mortality in the ceftazidime group.

    Area of Science:

    • Infectious Diseases
    • Clinical Pharmacology
    • Bacteriology

    Background:

    • Ceftazidime is a third-generation cephalosporin antibiotic.
    • Antibiotic resistance and treatment outcomes are critical in managing bacterial infections.

    Purpose of the Study:

    • To compare the clinical efficacy and safety of ceftazidime with other antibiotics.
    • To analyze treatment outcomes for staphylococcal and pseudomonas infections.

    Main Methods:

    • Analysis of clinical trial data from 2607 patients treated with ceftazidime and 466 patients treated with comparative antibiotics.
    • Evaluation of infection clearance, relapse, failure, adverse events, superinfections, and mortality rates.

    Main Results:

    • Ceftazidime showed 84% clearance for staphylococcal infections versus 82% for comparators. For pseudomonas infections, ceftazidime achieved 60% clearance compared to 43% for other agents.
    • Adverse events (8.9% vs 8.2%) and superinfections (2.5% vs 5.2%) were comparable. Mortality was lower with ceftazidime (3.3% vs 5.8%).
    • Factors like neutropenia influenced outcome differences.

    Conclusions:

    • Ceftazidime is effective for staphylococcal infections and shows improved outcomes for pseudomonas infections compared to other agents.
    • The safety profile of ceftazidime is comparable to other antibiotics, with a potential survival benefit.
    • Further analysis is needed to understand factors influencing treatment outcomes.

    More Related Videos

    Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

    Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

    Published on: July 24, 2021

    Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

    Assay Development for High-Throughput Drug Screening Against Mycobacteria

    Published on: October 25, 2024

    Related Concept Videos

    Combined Effects of Drugs: Synergism01:27

    Combined Effects of Drugs: Synergism

    Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
    Such synergistic combinations...
    Antiepileptic Drugs: Potassium Channel Activators01:20

    Antiepileptic Drugs: Potassium Channel Activators

    Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
    Ezogabine has gained approval as an adjunctive treatment...
    Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

    Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

    Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
    Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

    Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

    Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
    Urine Studies II: Urine Culture and Sensitivity Test01:26

    Urine Studies II: Urine Culture and Sensitivity Test

    A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
    Inhibitors of Bacterial DNA Synthesis01:28

    Inhibitors of Bacterial DNA Synthesis

    Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...